rimegepant   Click here for help

GtoPdb Ligand ID: 10704

Synonyms: BHV-3000 | BHV3000 | BMS-927711 | BMS927711 | compound 8 [PMID: 23153230] | Nurtec ODT® | Vydura®
Approved drug
rimegepant is an approved drug (FDA (2020), EMA (2022))
Compound class: Synthetic organic
Comment: Rimegepant (BMS-927711, BHV-3000) is a small molecule calcitonin gene-related peptide (CGRP) receptor antagonist [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 119.13
Molecular weight 534.22
XLogP 2.88
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(N1CCC(CC1)n1c(=O)[nH]c2c1cccn2)O[C@@H]1CC[C@H]([C@@H](c2c1nccc2)N)c1cccc(c1F)F
Isomeric SMILES O=C(N1CCC(CC1)n1c(=O)[nH]c2c1cccn2)O[C@@H]1CC[C@H]([C@@H](c2c1nccc2)N)c1cccc(c1F)F
InChI InChI=1S/C28H28F2N6O3/c29-20-6-1-4-17(23(20)30)18-8-9-22(25-19(24(18)31)5-2-12-32-25)39-28(38)35-14-10-16(11-15-35)36-21-7-3-13-33-26(21)34-27(36)37/h1-7,12-13,16,18,22,24H,8-11,14-15,31H2,(H,33,34,37)/t18-,22+,24-/m0/s1
InChI Key KRNAOFGYEFKHPB-ANJVHQHFSA-N
No information available.
Summary of Clinical Use Click here for help
In February 2020 the FDA approved rimegepant as an orally administered treatment for acute migraine. It is not indicated for migraine prevention.